-
Biotyx Medical Secures Over RMB 200 Million in Series B Financing for Iron-Based Stents
•
China-based Biotyx Medical (Shenzhen) Co.,Ltd, known as the world’s only developer of iron-based absorbable stents, has reportedly raised over RMB 200 million (USD 27.4 million) in a Series B financing round. The investors in this round include Gongqingcheng Huayi Private Equity Fund Management, Guangfa Qianhe Investment, IDG Capital, and Shanghai…
